Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-037419
Filing Date
2022-11-10
Accepted
2022-11-10 16:51:48
Documents
69
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mtem-10q_20220930.htm   iXBRL 10-Q 2786814
2 EX-10.1 mtem-ex101_59.htm EX-10.1 39432
3 EX-31.1 mtem-ex311_8.htm EX-31.1 8629
4 EX-31.2 mtem-ex312_6.htm EX-31.2 8499
5 EX-32.1 mtem-ex321_7.htm EX-32.1 10490
6 GRAPHIC g2ix2votuild000001.jpg GRAPHIC 82159
  Complete submission text file 0001564590-22-037419.txt   9269917

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA mtem-20220930.xsd EX-101.SCH 54398
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mtem-20220930_cal.xml EX-101.CAL 59570
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mtem-20220930_def.xml EX-101.DEF 157514
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtem-20220930_lab.xml EX-101.LAB 432893
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtem-20220930_pre.xml EX-101.PRE 307701
63 EXTRACTED XBRL INSTANCE DOCUMENT mtem-10q_20220930_htm.xml XML 1681083
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Filer) CIK: 0001183765 (see all company filings)

EIN.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32979 | Film No.: 221378171
SIC: 2834 Pharmaceutical Preparations